Effect of magnetic nanoparticles on apoptosis and cell cycle induced by wogonin in Raji cells

Traditional Chinese medicine is gradually becoming a new source of anticancer drugs. One such example is wogonin, which is cytotoxic to various cancer cell lines in vitro. However, due to its low water solubility, wogonin is restricted to clinical administration. Recently, the application of drug-coated magnetic nanoparticles (MNPs) to increase water solubility of the drug and to enhance its chemotherapeutic efficiency has attracted much attention. In this study, wogonin was conjugated with the drug delivery system of MNPs by mechanical absorption polymerization to fabricate wogonin-loaded MNPs. It was demonstrated that MNPs could strengthen wogonin-induced cell inhibition, apoptosis, and cell cycle arrest in Raji cells by methylthiazol tetrazolium assay, flow cytometer assay, and nuclear 4′,6-diamidino-2-phenylindole staining. Furthermore, the molecular mechanisms of these phenomena were explored by western blot, in which the protein levels of caspase 8 and caspase 3 were increased significantly while those of survivin and cyclin E were decreased significantly in wogonin-MNPs group. These findings suggest that the combination of wogonin and MNPs provides a promising strategy for lymphoma therapy.

[1]  V. Labhasetwar,et al.  Oh the irony: Iron as a cancer cause or cure? , 2011, Biomaterials.

[2]  Zhuang Liu,et al.  Polymer encapsulated upconversion nanoparticle/iron oxide nanocomposites for multimodal imaging and magnetic targeted drug delivery. , 2011, Biomaterials.

[3]  K. van Besien,et al.  Current status of allogeneic transplantation for aggressive non-Hodgkin lymphoma , 2011, Current opinion in oncology.

[4]  Maolan Li,et al.  Wogonin, an active ingredient of Chinese herb medicine Scutellaria baicalensis, inhibits the mobility and invasion of human gallbladder carcinoma GBC-SD cells by inducing the expression of maspin. , 2011, Journal of ethnopharmacology.

[5]  Baoan Chen,et al.  Study of the enhanced anticancer efficacy of gambogic acid on Capan-1 pancreatic cancer cells when mediated via magnetic Fe3O4 nanoparticles , 2011, International journal of nanomedicine.

[6]  F. Gao,et al.  Effect of magnetic Fe3O4 nanoparticles with 2-methoxyestradiol on the cell-cycle progression and apoptosis of myelodysplastic syndrome cells , 2011, International journal of nanomedicine.

[7]  A. Sánchez-Medina,et al.  The ethanol extract of Scutellaria baicalensis and the active compounds induce cell cycle arrest and apoptosis including upregulation of p53 and Bax in human lung cancer cells. , 2011, Toxicology and applied pharmacology.

[8]  Victor C Yang,et al.  Cancer theranostics: the rise of targeted magnetic nanoparticles. , 2011, Trends in biotechnology.

[9]  Neetu Singh,et al.  Nanoparticles that communicate in vivo to amplify tumour targeting. , 2011, Nature materials.

[10]  Mark B. Carter,et al.  The Targeted Delivery of Multicomponent Cargos to Cancer Cells via Nanoporous Particle-Supported Lipid Bilayers , 2011, Nature materials.

[11]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[12]  K. Barick,et al.  Development of citrate-stabilized Fe3O4 nanoparticles: Conjugation and release of doxorubicin for therapeutic applications , 2011 .

[13]  J. Wang,et al.  Wogonin induced apoptosis in human nasopharyngeal carcinoma cells by targeting GSK-3β and ΔNp63 , 2011, Cancer Chemotherapy and Pharmacology.

[14]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[15]  Pallab Pradhan,et al.  Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[16]  A. Lascialfari,et al.  Bovine serum albumin-based magnetic nanocarrier for MRI diagnosis and hyperthermic therapy: a potential theranostic approach against cancer. , 2010, Small.

[17]  F. Gao,et al.  Synergistic effect of magnetic nanoparticles of Fe3O4 with gambogic acid on apoptosis of K562 leukemia cells , 2009, International journal of nanomedicine.

[18]  F. Gao,et al.  The reversal effect of magnetic Fe3O4 nanoparticles loaded with cisplatin on SKOV3/DDP ovarian carcinoma cells , 2009, International journal of nanomedicine.

[19]  Jinwoo Cheon,et al.  Critical enhancements of MRI contrast and hyperthermic effects by dopant-controlled magnetic nanoparticles. , 2009, Angewandte Chemie.

[20]  M. Li‐Weber.  New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin. , 2009, Cancer treatment reviews.

[21]  Alain C. Mita,et al.  Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics , 2008, Clinical Cancer Research.

[22]  Lin Zhang,et al.  Role of p53, PUMA, and Bax in wogonin-induced apoptosis in human cancer cells. , 2008, Biochemical pharmacology.

[23]  Hui Liu,et al.  Antitumor activity of chloroform fraction of Scutellaria barbata and its active constituents , 2007, Phytotherapy research : PTR.

[24]  M. Treiber,et al.  Wogonin sensitizes resistant malignant cells to TNFalpha- and TRAIL-induced apoptosis. , 2006, Blood.

[25]  A. Gupta,et al.  Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies , 2004, IEEE Transactions on NanoBioscience.

[26]  P. Prasad,et al.  Aqueous Ferrofluid of Citric Acid Coated Magnetite Particles , 2003 .

[27]  Nathan Kohler,et al.  Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. , 2002, Biomaterials.

[28]  D. Nicholson,et al.  Caspase structure, proteolytic substrates, and function during apoptotic cell death , 1999, Cell Death and Differentiation.

[29]  Y. Ito,et al.  An antitumor promoter from Moringa oleifera Lam. , 1999, Mutation research.

[30]  C. Winterford,et al.  Apoptosis. Its significance in cancer and cancer Therapy , 1994, Cancer.

[31]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[32]  V. Devita.  Dose-response is alive and well. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.